Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127967602 | 12796760 | 2 | F | 20150716 | 20150826 | 20160929 | 20160929 | EXP | US-KOWA-15US001086 | KOWA PHARM | 53.00 | YR | M | Y | 0.00000 | 20160929 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127967602 | 12796760 | 1 | PS | LIVALO | PITAVASTATIN CALCIUM | 1 | 4 MG, QD | 22363 | 4 | MG | TABLET | QD | |||||||
127967602 | 12796760 | 2 | C | BABY ASPIRIN | ASPIRIN | 1 | UNK | 0 | |||||||||||
127967602 | 12796760 | 3 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | UNK | 0 | |||||||||||
127967602 | 12796760 | 4 | SS | ZETIA | EZETIMIBE | 1 | 10 MG, UNK | 0 | 10 | MG | QD | ||||||||
127967602 | 12796760 | 5 | C | LOVAZA | OMEGA-3-ACID ETHYL ESTERS | 1 | 1 G, QD | 0 | 1 | G | QD |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127967602 | 12796760 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127967602 | 12796760 | Blood creatine phosphokinase increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |